Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13
Mia Y. Masuda(Mayo Clinic in Arizona), Alfred D. Doyle(WinnMed), Samuel Flashner(Columbia University Irving Medical Center), Masataka Shimonosono(Kagoshima University), Koji Iijima(WinnMed), Hirohito Kita(Mayo Clinic), Takao Kobayashi(Japanese Society of Medical Oncology), Hiroshi Nakagawa(University of Pennsylvania), Rish K. Pai(University Hospitals of Cleveland), Matthew A. Rank(Mayo Clinic in Arizona), Arina Putikova(Mayo Clinic in Arizona), Andres J. Klein–Szanto, Nicholas Fritz(Arizona State University), Benjamin L. Wright(Phoenix Children's Hospital), Masaki Morimoto(Columbia University Irving Medical Center), Huijun Luo(Johnson University), Aliviya R. Schulze(WinnMed), Adelyn Dao(WinnMed), Grace C. Pyon(WinnMed), Danna R. Ortiz(WinnMed), William E. LeSuer(WinnMed)
Cited by 31
Related Papers
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|676
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|537
Skin Tumor-Promoting Activity of Benzoyl Peroxide, a Widely Used Free Radical-Generating Compound
|Science|1981|507
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|504
Rhinitis 2020: A practice parameter update
|Journal of Allergy and Clinical Immunology|2020|399